SEP 24, 2014 8:00 AM PDT

Role of Academic Institutions in Target Selection

Speaker
  • Director, Tri-I TDI
    Biography
      Michael Foley is the Director of the Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI), a newly formed partnership between Memorial Sloan Kettering , The Rockefeller University and Weill Cornell Medical College, to speed drug discovery. Foley brings 25 years of industry and academic experience to Tri-I TDI, helping to launch four companies and one academic institute and placing 12 drugs into clinical development. He was most recently the Director of the Chemical Biology Platform at the Broad Institute of MIT and Harvard. Michael was a co-founder of Infinity Pharmaceuticals and served as VP Chemistry from 2001 to 2006. He was also a co-founder of CombinatoRx and Forma Therapeutics, as well as working at Bristol-Myers Squibb and GlaxoSmithKline. He obtained his Ph.D. at Harvard, and helped establish the Harvard Institute of Chemistry and Cell Biology. In 2006, Michael joined the Broad Institute and served as director of the Therapeutics Platform. Foley received his B.S. in chemistry from St. Norbert College and his Ph.D. in chemistry from Harvard University.

    Abstract

    Target selection is arguably the most important decision in all drug discovery and development activities. No amount of great science can overcome the selection of the wrong target. The rapid expansion of potential targets for drug discovery as a result of modern genetic sequencing and analysis technologies has made target selection more challenging than ever before. This presentation will address the role of academic research centers in addressing the target selection problem


    Show Resources
    You May Also Like
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    FEB 24, 2021 10:00 AM PST
    C.E. CREDITS
    FEB 24, 2021 10:00 AM PST
    DATE: February 24, 2021 TIME: 10am PST Automated lab instruments such as liquid handlers and cell sorters are increasingly common in all types of laboratories, driving fast results for labor...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    SEP 24, 2014 8:00 AM PDT

    Role of Academic Institutions in Target Selection


    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources